Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Absence of mannose-binding lectin in a female with relapsing-remitting multiple sclerosis.
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Age-dependent effects on the treatment response of natalizumab in MS patients.
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Solodyn
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Sexual dysfunction ın multiple sclerosis: Gender differences.
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.

Pages